Anixa Biosciences Inc (ANIX) › Shareholders' EquityAnixa Biosciences Inc (ANIX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2009: $4.45M2010: $4.60M2011: $1.06M2012: -$1.19M2013: -$3.32M2014: $4.01M2015: $5.05M2016: $987.5K2017: $7.92M2018: $5.43M2019: $5.24M2020: $8.76M2021: $35.44M2022: $29.05M2023: $24.34M2024: $20.00M2025: $15.16M$15.16M2009Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$15.16M-24.2%2024$20.00M-17.8%2023$24.34M-16.2%2022$29.05M-18.0%2021$35.44M+304.5%2020$8.76M+67.3%2019$5.24M-3.7%2018$5.43M-31.4%2017$7.92M+702.3%2016$987.5K-80.5%2015$5.05M+26.0%2014$4.01M+220.7%2013-$3.32M-178.1%2012-$1.19M-212.9%2011$1.06M-77.0%2010$4.60M+3.2%2009$4.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share